MedPath

Fondaparinux Sodium

These highlights do not include all the information needed to use FONDAPARINUX SODIUM INJECTION safely and effectively. See full prescribing information for FONDAPARINUX SODIUM INJECTION. Initial U.S. Approval: 2001

Approved
Approval ID

49e0d7bc-3f49-849b-c77c-98682d1c0d19

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Sep 10, 2021

Manufacturers
FDA

Dr. Reddy's Laboratories Limited

DUNS: 650562841

Products 4

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Fondaparinux Sodium

PRODUCT DETAILS

NDC Product Code55111-678
Application NumberANDA091316
Marketing CategoryC73584
Route of AdministrationSUBCUTANEOUS
Effective DateAugust 18, 2018
Generic NameFondaparinux Sodium

INGREDIENTS (4)

sodium chlorideInactive
Code: 451W47IQ8X
Classification: IACT
fondaparinux sodiumActive
Quantity: 2.5 mg in 0.5 mL
Code: X0Q6N9USOZ
Classification: ACTIB
hydrochloric acidInactive
Code: QTT17582CB
Classification: IACT
sodium hydroxideInactive
Code: 55X04QC32I
Classification: IACT

Fondaparinux Sodium

PRODUCT DETAILS

NDC Product Code55111-679
Application NumberANDA091316
Marketing CategoryC73584
Route of AdministrationSUBCUTANEOUS
Effective DateAugust 18, 2018
Generic NameFondaparinux Sodium

INGREDIENTS (4)

sodium chlorideInactive
Code: 451W47IQ8X
Classification: IACT
fondaparinux sodiumActive
Quantity: 5 mg in 0.4 mL
Code: X0Q6N9USOZ
Classification: ACTIB
hydrochloric acidInactive
Code: QTT17582CB
Classification: IACT
sodium hydroxideInactive
Code: 55X04QC32I
Classification: IACT

Fondaparinux Sodium

PRODUCT DETAILS

NDC Product Code55111-680
Application NumberANDA091316
Marketing CategoryC73584
Route of AdministrationSUBCUTANEOUS
Effective DateAugust 18, 2018
Generic NameFondaparinux Sodium

INGREDIENTS (4)

fondaparinux sodiumActive
Quantity: 7.5 mg in 0.6 mL
Code: X0Q6N9USOZ
Classification: ACTIB
sodium hydroxideInactive
Code: 55X04QC32I
Classification: IACT
sodium chlorideInactive
Code: 451W47IQ8X
Classification: IACT
hydrochloric acidInactive
Code: QTT17582CB
Classification: IACT

Fondaparinux Sodium

PRODUCT DETAILS

NDC Product Code55111-681
Application NumberANDA091316
Marketing CategoryC73584
Route of AdministrationSUBCUTANEOUS
Effective DateAugust 18, 2018
Generic NameFondaparinux Sodium

INGREDIENTS (4)

sodium chlorideInactive
Code: 451W47IQ8X
Classification: IACT
sodium hydroxideInactive
Code: 55X04QC32I
Classification: IACT
fondaparinux sodiumActive
Quantity: 10 mg in 0.8 mL
Code: X0Q6N9USOZ
Classification: ACTIB
hydrochloric acidInactive
Code: QTT17582CB
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Fondaparinux Sodium - FDA Drug Approval Details